Evidence map›Paper›PMID 40836334›Full record

ArticleBMC infectious diseases2025

Epidemiology and surveillance of influenza, RSV and SARS-CoV-2 in children admitted with severe acute respiratory infection in West bengal, India from 2022 to 2023.

Tila Khan, Ranjan Saurav Das, Abhishek Jaiswal, Sayantan Halder, Rina Maity Majhi, Arabinda Mahato, Tarapada Ghosh, Parthasarathi Satpathi, Sangeeta Das Bhattacharya

Abstract read
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tila KhanSchool of Medical Science & Technology, Indian Institute of Technology Kharagpur, Kharagpur, 721302, India. tilakhaniitkgp@gmail.com.ORCID http://orcid.org/0000-0002-3422-1472
Ranjan Saurav DasSchool of Medical Science & Technology, Indian Institute of Technology Kharagpur, Kharagpur, 721302, India.
Abhishek JaiswalViral Research and Diagnostic Laboratory, Department of Microbiology, Midnapore Medical College & Hospital, Midnapore, India.
Sayantan HalderSchool of Medical Science & Technology, Indian Institute of Technology Kharagpur, Kharagpur, 721302, India.
Rina Maity MajhiSchool of Medical Science & Technology, Indian Institute of Technology Kharagpur, Kharagpur, 721302, India.
Arabinda MahatoPaediatrics, Kharagpur Sub Divisional Hospital, Kharagpur, India.
Tarapada GhoshDepartment of Paediatrics and Neonatology, Midnapore Medical College & Hospital, Midnapore, India.
Parthasarathi SatpathiViral Research and Diagnostic Laboratory, Department of Microbiology, Midnapore Medical College & Hospital, Midnapore, India.
Sangeeta Das BhattacharyaChristiana Care Health System, Newark, DE, USA.

Funding

Wellcome Trust DBT India Alliance IA/CPHE/19/1/504599
6 · The paper itself

Abstract

backgroundEvaluating the burden of respiratory syncytial virus (RSV) and influenza among young children in LMICs is crucial to inform implementation policies, given the importance of maternal influenza and RSV vaccination, which may not yet be widely available.

methodsThis study established a one-year surveillance of severe acute respiratory infection (SARI) from June 2022-2023 in hospitalized children 1-24 months from rural West Bengal India. We tested nasopharyngeal swabs collected from children admitted with SARI using multiplex real-time PCR for influenza, RSV, SARS-CoV-2, with a subset (N = 81) tested for additional respiratory pathogens and analyzed clinical features, factors influencing infections, and hospitalization duration.

resultsOf 1842 children admitted with SARI, 77% (1419) were between 1 and 24 months. Of 191 sampled, 21 required intensive care, and 3 died. The majority of mothers (83.7%) were vaccinated against COVID-19, but none against influenza, pertussis, or RSV. Viruses were detected in 44% (84/191), with RSV being the most common 60/190 (31.6%), followed by influenza 12/190 (6.3%), and SARS-CoV-2 2/191 (1%). Influenza subtypes included influenza A/H3 (6/16), A/H1N1pdm (5/16), Influenza B (4/16), and Influenza C (1/16). RSV peaked during autumn, influenza during winter and monsoon. Influenza was more common in infants < 6 months (13.4%, p = 0.03). RSV affected both infants under 6 months and over similarly (34% vs. 29.6%, p = 0.5). Infants < 6 months frequently required oxygen support (p = 0.02), though ICU admissions were similar (p = 0.98). RSV was associated with 19% of ICU admissions and influenza with 14%. Additional pathogens included Haemophilus influenzae (23.45%), Streptococcus pneumoniae (22%), rhinovirus (13.6%), parainfluenza virus group (6.1%), Staphylococcus aureus (8.6%), Moraxella catarrhalis (5%), bocavirus (3.7%), adenovirus (3.7%), Chlamydia pneumoniae (1%), and Bordetella (1%). Viral-bacterial co-detection occurred in 34%, especially in infants < 6 months. Children with RSV had increased risk of having S. pneumoniae [Odds Ratio OR 6.2, 95% CI 1.8-21.3]. Rhinovirus cases were associated with ICU admission, mechanical ventilation, and longer length of stay, regardless of age.

conclusionRSV and influenza were the key contributors to SARI in children under-2. Findings highlight the need for diagnostics to guide vaccination, reduce antibiotic use, and improve indoor air quality for alleviating the SARI burden in rural settings.

Indexed as

COVID-19Influenza, HumanRespiratory Syncytial Virus InfectionsRespiratory Tract InfectionsChild, PreschoolEpidemiological MonitoringFemaleHospitalizationHumansIndiaInfantMaleNasopharynxRespiratory Syncytial Virus, HumanSARS-CoV-2ChildrenEpidemiologyInfantInfluenzaRespiratory Syncytial VirusRespiratory tract infectionsRespiratory virusesSARS-CoV-2Severe Acute Respiratory Infection

Identifiers

PMID40836334
PMCPMC12366160

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.